You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 47 No. 10, October 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Atypical Depression, Panic Attacks, and Response to Imipramine and Phenelzine

A Replication

Frederic M. Quitkin, MD; Patrick J. McGrath, MD; Jonathan W. Stewart, MD; Wilma Harrison, MD; Elaine Tricamo, RN; Steven G. Wager, MD; Katja Ocepek-Welikson, MPhil; Edward Nunes, MD; Judith G. Rabkin, PhD; Donald F. Klein, MD

Arch Gen Psychiatry. 1990;47(10):935-941.


Abstract

• In an initial study with 120 patients with reactive mood and associated atypical symptoms, phenelzine sulfate was superior to imipramine hydrochloride and placebo. Since their response to phenelzine appears to be unique, this suggests that atypical depression may be a distinct subgroup of unipolar depressive illness. Unexpectedly, the benefit of antidepressants was limited to patients who also had spontaneous panic attacks. To help establish the validity of this syndrome, a new sample of 90 atypical depressives was studied. The clinical and demographic characteristics of the original and replication sample were virtually identical at baseline. In addition, the treatment response with either placebo, imipramine, or phenelzine was also indistinguishable in the two patient groups. The outcome in the replication study supports the hypothesis that this may be a distinct unipolar depressive subgroup. In the replication sample, a history of panic attacks did not appear to be a relevant predictor. We discuss the explanations for this discrepancy in the two patient samples.



Author Affiliations

From the Department of Psychiatry, Columbia University, New York, NY, and the New York (NY) State Psychiatric Institute.


Footnotes

Accepted for publication December 7, 1989.

Reprint requests to New York State Psychiatric Institute, 722 W 168th St, Box 12, New York, NY 10032 (Dr Quitkin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Psychopharmacology: Underuse of Evidence-Based Pharmacotherapies for Affective Disorders
Dwight-Johnson et al.
Psychiatr. Serv. 2003;54:1076-1078.
FULL TEXT  

Depression With Atypical Features in the National Comorbidity Survey: Classification, Description, and Consequences
Matza et al.
Arch Gen Psychiatry 2003;60:817-826.
ABSTRACT | FULL TEXT  

A Reappraisal of Atypical Depression
QUITKIN et al.
Am. J. Psychiatry 2003;160:798-800.
FULL TEXT  

Are There Differences Between Women's and Men's Antidepressant Responses?
Quitkin et al.
Am. J. Psychiatry 2002;159:1848-1854.
ABSTRACT | FULL TEXT  

Atypical Depression: A Reappraisal
Parker et al.
Am. J. Psychiatry 2002;159:1470-1479.
ABSTRACT | FULL TEXT  

Classifying Depression
QUITKIN et al.
Am. J. Psychiatry 2001;158:1332-1333.
FULL TEXT  

Pros and Cons of Prozac and Its Relatives
Am. J. Psychiatry 2000;157:323-325.
FULL TEXT  

A Placebo-Controlled Study of Fluoxetine Versus Imipramine in the Acute Treatment of Atypical Depression
McGrath et al.
Am. J. Psychiatry 2000;157:344-350.
ABSTRACT | FULL TEXT  

Treatment of Atypical Depression With Cognitive Therapy or Phenelzine: A Double-blind, Placebo-Controlled Trial
Jarrett et al.
Arch Gen Psychiatry 1999;56:431-437.
ABSTRACT | FULL TEXT  

Treating Major Depression in Primary Care Practice: An Update of the Agency for Health Care Policy and Research Practice Guidelines
Schulberg et al.
Arch Gen Psychiatry 1998;55:1121-1127.
ABSTRACT | FULL TEXT  

Latent Class Analysis of Lifetime Depressive Symptoms in the National Comorbidity Survey
Sullivan et al.
Am. J. Psychiatry 1998;155:1398-1406.
ABSTRACT | FULL TEXT  

The Identification and Validation of Distinct Depressive Syndromes in a Population-Based Sample of Female Twins
Quitkin et al.
Arch Gen Psychiatry 1997;54:970-972.
ABSTRACT  

Chronological Milestones to Guide Drug Change: When Should Clinicians Switch Antidepressants?
Quitkin et al.
Arch Gen Psychiatry 1996;53:785-792.
ABSTRACT  

Response to Phenelzine and Imipramine in Placebo Nonresponders With Atypical Depression: A New Application of the Crossover Design
Quitkin et al.
Arch Gen Psychiatry 1991;48:319-323.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.